Research guide
Peptides for Fat Loss
A plain-language map of the compounds most often referenced in fat-loss and metabolic research — what pathways they affect, how they differ, and the dosing ranges cited in published protocols. Everything here is for laboratory research use only.
How the research groups these compounds
Fat-loss research can be divided into three mechanisms. The first is appetite and energy-expenditure signaling: incretin-based triple agonists like Retatrutide reduce food intake and raise energy expenditure in research models. The second is direct lipolysis: AOD-9604 is the hGH-derived fragment studied for fat-mobilization without the broader anabolic signaling of full-length GH.
The third is metabolic support and lean-mass preservation: Tesamorelin reduces visceral adipose tissue while supporting endogenous GH, MOTS-c is studied for AMPK activation and glucose handling, and CJC-1295 + Ipamorelin is used in recomposition research to protect lean tissue during a deficit.
A focused research stack usually pairs one appetite/energy compound with one lipolytic or metabolic-support peptide. Adding every compound at once adds complexity, not extra fat loss.
Compound reference
Dosing ranges below are the values cited in research literature, not recommendations.
Retatrutide 10mg
MetabolicTriple-agonist (GIP/GLP-1/glucagon) studied for large reductions in adiposity and food-intake signaling in research models.
Research range: Research literature commonly cites 1–4 mg weekly ranges, titrated upward over several weeks.
- Route
- Not reproduced on this page — see the research-use disclaimer above.
- Frequency
- Not reproduced on this page — see the research-use disclaimer above.
- Timing
- Not reproduced on this page — see the research-use disclaimer above.
- Cycle length
- 12–24 week research blocks are commonly cited in the literature.
- Handling
- Handling, reconstitution and storage steps are not reproduced here; refer to the original published methodology.
Protocol reference
AOD-9604
LipolyticFragment of hGH (176-191) investigated for lipolytic activity without meaningful effect on IGF-1 in research models.
Research range: Commonly referenced at 250–500 mcg daily, fasted, in published research protocols.
- Route
- Not reproduced on this page — see the research-use disclaimer above.
- Frequency
- Not reproduced on this page — see the research-use disclaimer above.
- Timing
- Not reproduced on this page — see the research-use disclaimer above.
- Cycle length
- 8–12 week research blocks are commonly cited in the literature.
- Handling
- Handling, reconstitution and storage steps are not reproduced here; refer to the original published methodology.
Protocol reference
Tesamorelin
GHRH analogGHRH analog most studied for reduction of visceral adipose tissue while supporting endogenous GH pulsatility.
Research range: Research ranges of 1–2 mg nightly are frequently cited.
- Route
- Not reproduced on this page — see the research-use disclaimer above.
- Frequency
- Not reproduced on this page — see the research-use disclaimer above.
- Timing
- Not reproduced on this page — see the research-use disclaimer above.
- Cycle length
- 12–26 week research blocks are commonly cited in the literature.
- Handling
- Handling, reconstitution and storage steps are not reproduced here; refer to the original published methodology.
Protocol reference
MOTS-c
MitochondrialMitochondrial-derived peptide studied for AMPK activation, glucose handling and exercise-capacity markers.
Research range: Research ranges of 5–10 mg weekly, often split across 2–3 doses.
- Route
- Not reproduced on this page — see the research-use disclaimer above.
- Frequency
- Not reproduced on this page — see the research-use disclaimer above.
- Timing
- Not reproduced on this page — see the research-use disclaimer above.
- Cycle length
- 4–8 week research blocks are commonly cited in the literature.
- Handling
- Handling, reconstitution and storage steps are not reproduced here; refer to the original published methodology.
Protocol reference
CJC-1295 + Ipamorelin 5mg
GH secretagogueClassic blend pairing a GHRH analog with a selective ghrelin-receptor agonist; studied for amplified GH pulse amplitude with minimal cortisol/prolactin shift.
Research range: Commonly cited at 100–200 mcg of each, 1–2x daily before sleep.
- Route
- Not reproduced on this page — see the research-use disclaimer above.
- Frequency
- Not reproduced on this page — see the research-use disclaimer above.
- Timing
- Not reproduced on this page — see the research-use disclaimer above.
- Cycle length
- 8–12 week research blocks are commonly cited in the literature.
- Handling
- Handling, reconstitution and storage steps are not reproduced here; refer to the original published methodology.
Protocol reference
GLU750
Metabolic supportGlutathione-based formulation studied for oxidative-stress buffering alongside metabolic research protocols.
Research range: Research ranges of 200–600 mg weekly.
- Route
- Not reproduced on this page — see the research-use disclaimer above.
- Frequency
- Not reproduced on this page — see the research-use disclaimer above.
- Timing
- Not reproduced on this page — see the research-use disclaimer above.
- Cycle length
- 8–12 week research blocks are commonly cited in the literature.
- Handling
- Handling, reconstitution and storage steps are not reproduced here; refer to the original published methodology.
Protocol reference
Dose-escalation and reconstitution details are not published on this page, as they read as administration instructions rather than research description. Consult the original published methodology for that information.
Example research pairings
- Aggressive adiposity reduction: Retatrutide + Tesamorelin. Combines appetite/energy signaling with GHRH-driven visceral-fat reduction in research models.
- Targeted lipolysis without GH-axis load: AOD-9604 + MOTS-c. AOD-9604 is studied for direct fat-mobilization, while MOTS-c adds AMPK/metabolic support.
- Recomposition / deficit preservation: CJC-1295 + Ipamorelin with Tesamorelin. GH-axis support to retain lean tissue while reducing fat mass in research protocols.
- Oxidative stress buffering: GLU750 alongside a metabolic stack. Studied for glutathione-mediated support during higher-volume metabolic research.
What the research does not show
None of these compounds replace a caloric deficit, resistance training, adequate protein or sleep. Published effects are measured against controlled diet and activity variables, and outcomes are typically modest, time-bound and protocol-specific. More is not better: research stacks are intentionally limited to 2–4 compounds to avoid overlapping mechanism redundancy.
Frequently asked questions
Which peptides are most studied for fat loss?
Retatrutide (a triple GIP/GLP-1/glucagon agonist), Tesamorelin (a GHRH analog targeting visceral adipose tissue), AOD-9604 (the lipolytic fragment of hGH 176-191), and MOTS-c (a mitochondrial-derived peptide influencing AMPK and glucose handling) are the most frequently cited in adiposity research.
Do fat-loss peptides work without diet or exercise?
No. Research models consistently pair these compounds with a controlled energy intake and activity stimulus. They are modifiers of appetite, energy expenditure, or substrate use — not replacements for a caloric deficit or resistance training.
What is the difference between Retatrutide and AOD-9604?
Retatrutide acts on incretin and glucagon receptors to reduce food intake and increase energy expenditure in research models. AOD-9604 is a localized lipolytic fragment of growth hormone that does not raise IGF-1 in the same way; the research focuses on its ability to stimulate fat breakdown without broader GH-axis effects.
How does Tesamorelin fit into a fat-loss stack?
Tesamorelin is a GHRH analog best known in research for reducing visceral adipose tissue while preserving lean mass. It raises endogenous GH pulsatility, which may also support sleep and recovery during a deficit.
Are these compounds legal to buy?
The compounds discussed here are sold and referenced for laboratory research use only. They are not approved drugs, dietary supplements, or products for human or veterinary consumption.
Build a stack for your own goal
Answer three questions and the hub matches 2–4 compounds to your goal, experience level and focus areas.
Open the stack builderOr read the muscle-building research guide.
For research purposes only. Not intended for human consumption. Consult a qualified professional.
Research disclaimer: All compounds referenced on this page are intended for laboratory research use only. They are not drugs, dietary supplements, or products for human or veterinary consumption. Nothing here is medical advice, and no dosing figure is a recommendation. Consult a qualified physician before making any health decision.